Jove
Visualize
Contact Us

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Clinical Practice Guidelines for Chronic Hepatitis B: Natural History Classification and Treatment Initiation.

Clinical and molecular hepatology·2026
Same author

Metabolomics Approach Identifies Predictive Serum Markers for Hepatocellular Carcinogenesis Following Hepatitis C Virus Elimination.

Cancers·2026
Same author

Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same author

Genomic and transcriptomic profiling of hepatocellular carcinoma in patients with Fontan-associated liver disease.

Hepatology (Baltimore, Md.)·2026
Same author

Preclinical assessment of oral TLR7 agonist SA-5 in a nonhuman primate model.

JCI insight·2025
Same author

Precision Strategy for Hepatocellular Carcinoma Surveillance after Hepatitis C Cure: Debates across Guidelines.

Gut and liver·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 4, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Virus associated innate immunity in liver.

Tatsuya Kanto1

  • 1Department of Gastroenterology, Osaka University Graduate School of Medicine, Suita, Japan. kantot@gh.med.osaka-u.ac.jp

Frontiers in Bioscience : a Journal and Virtual Library
|May 30, 2008
PubMed
Summary

Hepatitis C virus (HCV) impairs dendritic cell (DC) and natural killer (NK) cell immune responses. Therapeutic interventions can restore DC function, crucial for controlling HCV infection.

Area of Science:

  • Immunology
  • Virology
  • Hepatology

Background:

  • Dendritic cells (DCs) are crucial for initiating antiviral immune responses via toll-like receptors (TLR) and RIG-I.
  • Hepatitis C virus (HCV) infection is associated with impaired DC and NK cell functions, contributing to viral persistence.
  • Dysfunctional immune signaling in myeloid DCs (MDCs) and altered NK cell activity are observed in HCV patients.

Purpose of the Study:

  • To investigate the functional alterations of dendritic cells (DCs) and innate lymphocytes in Hepatitis C Virus (HCV) infection.
  • To elucidate the mechanisms underlying immune evasion and dysfunction in the context of HCV.
  • To assess the impact of therapy on immune cell function and viral clearance.

Main Methods:

  • Analysis of TLR/RIG-I-mediated cytokine induction (IFN-beta, TNF-alfa) in myeloid DCs (MDCs) from HCV patients.

More Related Videos

Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice
11:44

Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice

Published on: March 24, 2015

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Related Experiment Videos

Last Updated: Jul 4, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice
11:44

Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice

Published on: March 24, 2015

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

  • Assessment of DC responsiveness to interferon-alfa and subsequent NK cell activation.
  • Evaluation of NK cell-mediated DC regulation via cytokines (IL-10, TGF-beta1) and receptor expression (NKG2A/CD94).
  • Characterization of NKT cell cytokine profiles (IL-13, IFN-gamma).
  • Main Results:

    • MDCs from HCV patients exhibit reduced TLR/RIG-I-mediated IFN-beta and TNF-alfa induction, indicating impaired signaling.
    • DCs in HCV infection are unresponsive to interferon-alfa, leading to diminished NK cell activation.
    • NK cells from HCV patients down-regulate DCs, associated with increased NKG2A/CD94 expression.
    • NKT cells from HCV patients show a Th2-biased response with increased IL-13 production.
    • Successful pegylated interferon-alfa/ribavirin therapy correlates with improved DC function and HCV eradication.

    Conclusions:

    • Cross-talk between DCs and innate lymphocytes is critical for immune responses against HCV.
    • Therapeutic strategies targeting immune modulation can restore DC function and aid in HCV clearance.
    • Understanding these cellular interactions provides insights into spontaneous and treatment-induced viral control.